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Introduction
Several innovative models for primary care delivery have
recently been introduced in Ontario, Canada. These
group-practice models share common characteristics of
patient rostering, age-sex based capitation rates, and per-
formance-based incentives. These models have been
adopted because of their potential strengths to reduce the
overall cost of care, improve effective medical care man-
agement, and increase the use of appropriate preventative-
care measures. There is concern, however, that age-sex
adjusted capitation rates alone do not take into account
variations in the morbidity burden and the healthcare
needs that are associated with socioeconomic status.
The objective of this study is to compare capitation remu-
neration rates, by socioeconomic status (SES), with the
morbidity burden and the expected primary care resource
use of patients enrolled to primary care physicians in the
most established capitation model -- Family Health Net-
works (FHN).
Results
The study sample consisted of 487,131 patients enrolled
to 507 physicians in 53 group practices continuously from
September 1, 2005 to August 31, 2006. The number of
ADGs (types of diagnosed conditions) and ACG weights
(relative expected resource use) was higher among
women, and increased incrementally with increasing age.
This finding was consistent across income quintiles.
Low SES was associated with a higher average number of
ADGs compared to the highest SES (2.7 vs 2.9; p < 0.001).
Average ACG weights were higher in the low SES category
compared to the highest (0.65 vs. 0.55; p < 0.001). The
average capitation rate increased incrementally with
decreasing SES; however, it did not increase at the same
rate as the measures of expected resource use. Both the
standardized average ADG count, and ACG weight of
those in the lowest income group, were higher than the
average capitation rate. The opposite was true for those in
the highest income group.
Conclusion
Age-sex adjusted capitation rates do take into account
some of the variation in the morbidity burden and the
expected healthcare resource utilization that exists across
the SES spectrum. However, the physician reimbursement
system in FHNs does not take into account all of the vari-
ation in morbidity burden that is associated with socioe-
conomic status. There is a risk that adjusting capitation
rates for age and sex alone introduces an incentive to pref-
erentially enrol patients with higher socioeconomic sta-
tus, or to practice in geographic areas where residents have
higher incomes.
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